Literature DB >> 20506119

EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.

Joerg Kumbrink1, Kathrin H Kirsch, Judith P Johnson.   

Abstract

The inducible zinc finger transcription factors EGR1, EGR2, and EGR3 regulate the expression of numerous genes involved in differentiation, growth, and response to extracellular signals. Their activity is modulated in part through NAB2 which is induced by the same stimuli. In melanoma and carcinoma cells EGR1 activates NAB2 expression. In T lymphocytes EGR2 and EGR3 have been shown to inhibit NAB2 expression. Therefore, we investigated the influence of EGR2 and EGR3 on NAB2 expression in melanoma and carcinoma cells. Here, we show that like EGR1, EGR2 and EGR3 induced NAB2 expression in these cells. EGR1 and EGR3 act in concert on the NAB2 promoter and are more potent activators of NAB2 transcription than EGR2. EGR1-, EGR2-, and EGR3-induced NAB2 promoter activity is mediated through similar cis-regulatory elements and the activation by each EGR is repressed by NAB2. Kinetic studies suggest that induction of EGR1 leads to low NAB2 expression, while EGR2 and EGR3 are necessary for maximal and sustained expression. As already shown for EGR1, reduction of EGR2 or EGR3 expression by siRNAs reduced endogenous NAB2 levels. Depletion of EGR3 also resulted in a reduction of EGR2 levels confirming EGR2 as a target gene of EGR3. Our results suggest that in many cells of neuroectodermal and epithelial origin EGR1, EGR2, and EGR3 activate NAB2 transcription which is in turn repressed by NAB2, thus establishing a negative feedback loop. This points to a complex relationship between the EGR factors and NAB2 expression likely depending on the cellular context. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20506119      PMCID: PMC2930072          DOI: 10.1002/jcb.22690

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  40 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Regulation of life and death by the zinc finger transcription factor Egr-1.

Authors:  Gerald Thiel; Giuseppe Cibelli
Journal:  J Cell Physiol       Date:  2002-12       Impact factor: 6.384

3.  A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene.

Authors:  B R Sevetson; J Svaren; J Milbrandt
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

4.  Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.

Authors:  Rüdiger Neef; Martina A Kuske; Elma Pröls; Judith P Johnson
Journal:  Cancer Res       Date:  2002-10-15       Impact factor: 12.701

5.  Impaired prostate tumorigenesis in Egr1-deficient mice.

Authors:  S A Abdulkadir; Z Qu; E Garabedian; S K Song; T J Peters; J Svaren; J M Carbone; C K Naughton; W J Catalona; J J Ackerman; J I Gordon; P A Humphrey; J Milbrandt
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression.

Authors:  R Nagarajan; J Svaren; N Le; T Araki; M Watson; J Milbrandt
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

7.  Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma.

Authors:  S A Abdulkadir; J M Carbone; C K Naughton; P A Humphrey; W J Catalona; J Milbrandt
Journal:  Hum Pathol       Date:  2001-09       Impact factor: 3.466

8.  NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells.

Authors:  Markus Lucerna; Diana Mechtcheriakova; Alexandra Kadl; Gernot Schabbauer; Romana Schäfer; Florian Gruber; Yuri Koshelnick; Horst-Dietmar Müller; Katja Issbrücker; Matthias Clauss; Bernd R Binder; Erhard Hofer
Journal:  J Biol Chem       Date:  2002-11-08       Impact factor: 5.157

9.  Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus.

Authors:  M U Ehrengruber; S G Muhlebach; S Söhrman; C M Leutenegger; H A Lester; N Davidson
Journal:  Gene       Date:  2000-11-27       Impact factor: 3.688

10.  Hepatocyte growth factor induced up-regulations of VEGF through Egr-1 in hepatocellular carcinoma cells.

Authors:  Kyung Hee Lee; Jae-Ryong Kim
Journal:  Clin Exp Metastasis       Date:  2009-06-13       Impact factor: 5.150

View more
  37 in total

Review 1.  Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy.

Authors:  Swati Bhattacharyya; Minghua Wu; Feng Fang; Warren Tourtellotte; Carol Feghali-Bostwick; John Varga
Journal:  Matrix Biol       Date:  2011-04-13       Impact factor: 11.583

2.  Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action.

Authors:  Ramesh Chandra; T Chase Francis; Prasad Konkalmatt; Ariunzaya Amgalan; Amy M Gancarz; David M Dietz; Mary Kay Lobo
Journal:  J Neurosci       Date:  2015-05-20       Impact factor: 6.167

3.  Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.

Authors:  Joerg Kumbrink; Kathrin H Kirsch
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

4.  Nab2 maintains thymus cellularity with aging and stress.

Authors:  K Taraszka Hastings; Diana Elizalde; Leela Muppana; Sarah Levine; Christy M Kamel; Wendy M Ingram; Jennifer T Kirkpatrick; Chengcheng Hu; Matthew P Rausch; Amelia L Gallitano
Journal:  Mol Immunol       Date:  2017-03-08       Impact factor: 4.407

5.  Early growth response-2 signaling mediates immunomodulatory effects of human multipotential stromal cells.

Authors:  Dominique J Barbeau; Kiet Tran La; Duk Soo Kim; Svetoslava S Kerpedjieva; Galina V Shurin; Kenichi Tamama
Journal:  Stem Cells Dev       Date:  2013-10-05       Impact factor: 3.272

6.  Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors/hemangiopericytomas.

Authors:  Yunan Han; Qingfu Zhang; Xinmiao Yu; Xu Han; Huan Wang; Yingying Xu; Xueshan Qiu; Feng Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes.

Authors:  Kathleen A Worringer; Tim A Rand; Yohei Hayashi; Salma Sami; Kazutoshi Takahashi; Koji Tanabe; Megumi Narita; Deepak Srivastava; Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2013-11-14       Impact factor: 24.633

8.  p130Cas acts as survival factor during PMA-induced apoptosis in HL-60 promyelocytic leukemia cells.

Authors:  Joerg Kumbrink; Kathrin H Kirsch
Journal:  Int J Biochem Cell Biol       Date:  2012-12-31       Impact factor: 5.085

9.  Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells.

Authors:  Andrei P Drabovich; Maria P Pavlou; Christina Schiza; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2016-04-11       Impact factor: 5.911

10.  Fat-specific protein 27 inhibits lipolysis by facilitating the inhibitory effect of transcription factor Egr1 on transcription of adipose triglyceride lipase.

Authors:  Maneet Singh; Rajween Kaur; Mi-Jeong Lee; R Taylor Pickering; Vishva Mitra Sharma; Vishwajeet Puri; Konstantin V Kandror
Journal:  J Biol Chem       Date:  2014-04-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.